Article Versions Notes

Séguy L, Guyon L, Maurel M, Verdié P, Davis A, Corvaisier S, Lisowski V, Dallemagne P, Groo A-C, Malzert-Fréon A. Active Targeted Nanoemulsions for Repurposing of Tegaserod in Alzheimer’s Disease Treatment. Pharmaceutics. 2021; 13(10):1626. https://doi.org/10.3390/pharmaceutics13101626

Séguy, Line, Léna Guyon, Manon Maurel, Pascal Verdié, Audrey Davis, Sophie Corvaisier, Vincent Lisowski, Patrick Dallemagne, Anne-Claire Groo, and Aurélie Malzert-Fréon. 2021. "Active Targeted Nanoemulsions for Repurposing of Tegaserod in Alzheimer’s Disease Treatment" Pharmaceutics 13, no. 10: 1626. https://doi.org/10.3390/pharmaceutics13101626

Séguy, L., Guyon, L., Maurel, M., Verdié, P., Davis, A., Corvaisier, S., Lisowski, V., Dallemagne, P., Groo, A.-C., & Malzert-Fréon, A. (2021). Active Targeted Nanoemulsions for Repurposing of Tegaserod in Alzheimer’s Disease Treatment. Pharmaceutics, 13(10), 1626. https://doi.org/10.3390/pharmaceutics13101626